EMERGENT BIOSOLUTIONS INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was -$800.00K, a 500.00% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $200.00K.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was -$2.10M, a 290.91% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2024-12-31 | -$800.00K 10-K · filed 2026-02-27 |
| 2023-12-31 | $200.00K 10-K · filed 2026-02-27 |
| 2022-12-31 | -$2.10M 10-K · filed 2025-03-04 |
| 2021-12-31 | $1.10M 10-K · filed 2024-03-08 |
| 2020-12-31 | $400.00K 10-K/A · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |